EP Vantage

Newsletter provider, biotech, healthcare
EP Vantage
Newsletter provider, biotech, healthcare
Contributor since: 2008
Company: EP Vantage
Sorry, that $80m figure actually relates to royalties, not sales.
So assuming a 20% royalty rate, sales for the entire franchise (Gralise + Serada) in 2016 could reach £$400m.
All sales and royalty forecasts are taken from a consensus of analyst estimates.
Hope that clarifies.